shim
Abbott A Annual Report 2006 signature
Page 13 of 40
shim

Pharmaceuticals

Abbott focuses on breakthrough science to develop effective treatments and solve unmet medical needs. We also continue to pursue new indications for existing medications that offer physicians important treatment options.

Tricor and Niaspan

Tricor and Niaspan

TriCor is the market-leading fenofibrate for reducing high triglycerides, fat found in the blood that builds up in the arteries over time. Niaspan primarily raises HDL, or good cholesterol.

Kaletra

Kaletra

Kaletra is a leading treatment for HIV. Kaletra tablets offer patients improved convenience without compromising critical viral suppression.

 
Zemplar

Zemplar

Zemplar is a leading treatment for secondary hyperparathyroidism, a complication of chronic kidney disease. Zemplar is offered intravenously or in capsule form.

Depakote ER

Depakote ER

Depakote ER is a once-daily treatment for certain types of epilepsy, mania in bipolar disorder and the prevention of migraine headaches.

 
Synthroid

Synthroid

Synthroid is the number-one-prescribed treatment for thyroid disease, in conditions where the thyroid gland does not produce enough thyroid hormone.

Omnicef

Omnicef

Omnicef, a great-tasting oral suspension antibiotic, is offered in a strawberry cream flavor children prefer.

 
shim